• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
N/A
| Market Cap | 190.873 Million | Shares Outstanding | 8.68 Million | Avg 30-day Volume | 43.441 Thousand |
| P/E Ratio | 36.5698 | Dividend Yield | 1.6408 | EPS | 0.6 |
| Price to Revenue | 3.0172 | Debt to Equity | 0.0394 | EBITDA | 10.7 Million |
| Price to Book Value | 2.677 | Operating Margin | 14.2866 | Enterprise Value | 171.728 Million |
| Current Ratio | 5.867 | EPS Growth | -0.294 | Quick Ratio | 3.294 |
| 1 Yr BETA | 0.8166 | 52-week High/Low | 0.0 / | Profit Margin | 8.2506 |
| Operating Cash Flow Growth | -17.5592 | Altman Z-Score | 12.5411 | Free Cash Flow to Firm | -27.616 Thousand |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
15,602 | 2021-02-04 | 0 | |
|
0 | 2021-02-04 | 0 | |
|
SOFINNOVA VENTURE PARTNERS X, L.P. |
|
0 | 2021-02-04 | 0 |
|
14,285 | 2021-02-04 | 0 | |
|
76,903 | 2021-02-04 | 0 | |
|
YONEHIRO GRANT CHIEF BUSINESS OFFICER |
|
0 | 2021-02-04 | 0 |
|
SCHATZMAN RANDALL C CHIEF EXECUTIVE OFFICER |
|
0 | 2021-02-04 | 0 |
|
0 | 2021-02-04 | 0 | |
|
QUINN WILLIAM P. CHIEF FINANCIAL OFFICER |
|
12,698 | 2021-02-04 | 0 |
|
DORNAN DAVID CHIEF SCIENTIFIC OFFICER |
|
0 | 2021-02-04 | 0 |
|
PEREZ EDITH A. CHIEF MEDICAL OFFICER |
|
0 | 2021-02-04 | 0 |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2014-11-18 | 0 | |
|
ANDREWS WILLIAM C VICE PRESIDENT |
|
No longer subject to file | 2014-11-18 | 0 |
|
No longer subject to file | 2014-11-18 | 0 | |
|
No longer subject to file | 2012-09-26 | 0 | |
|
SHAFF GERALD H |
|
20,000 | 2007-10-05 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
